Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
SAILIFE

Sai Life Science Share Price

 

 

Sai Life Science live price: ₹1024.95. It opened at ₹1,051 vs previous close ₹1,042; intraday high/low: ₹1,055/₹1,017. The 50 & 200 DMA stand at ₹967.97/₹887.89.

Sai Life Science Performance

  • Today's Low
  • ₹1,017
  • Today's High
  • ₹1,055
  • 52 Week Low
  • ₹675
  • 52 Week High
  • ₹1,084
  • Open Price₹1,051
  • Previous Close₹1,042
  • Volume458,182
  • 50 DMA₹967.97
  • 100 DMA₹938.60
  • 200 DMA₹887.89

Sai Life Science Chart

Investment Returns

  • Over 1 Month + 1.24%
  • Over 3 Month + 28.92%
  • Over 6 Month + 14.51%
  • Over 1 Year + 49.04%

Smart Investing Starts Here Start SIP with Sai Life Science for Steady Growth!

Invest Now

Sai Life Science Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 65.3
  • PEG Ratio
  • 0.5
  • Market Cap Cr
  • 21,731
  • P/B Ratio
  • 9.2
  • Average True Range
  • 36.77
  • EPS
  • 16.01
  • Dividend Yield
  • 0
  • MACD Signal
  • 4.29
  • RSI
  • 59.5
  • MFI
  • 54.64

Sai Life Science Financials

Sai Life Science Technicals

EMA & SMA

Current Price
₹1,024.95
-16.65 (-1.6%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹987.73
  • 50 Day
  • ₹967.97
  • 100 Day
  • ₹938.60
  • 200 Day
  • ₹887.89

Resistance and Support

1032.18 Pivot Speed
  • R3 1,084.97
  • R2 1,069.78
  • R1 1,047.37
  • S1 1,009.77
  • S2 994.58
  • S3 972.17

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Sai Life Sciences, a leading CRDMO, partners with 280+ global pharma and biotech companies to accelerate NCE small molecule programs. across India, UK, USA, and Japan, it ensures quality and compliance through USFDA-certified facilities.

Sai Life Sciences Ltd has an operating revenue of Rs. 2,169.86 Cr. on a trailing 12-month basis. An annual revenue growth of 16% is outstanding, Pre-tax margin of 13% is healthy, ROE of 7% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 7% and 16% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 3% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 99 which is a GREAT score indicating consistency in earnings, a RS Rating of 88 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 57 indicates it belongs to a fair industry group of Medical-Biomed/Biotech and a Master Score of A is the best. Overall, the stock has great fundamentals and technical strength to stay in momentum.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Sai Life Science Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-14 Audited Results
2026-02-05 Quarterly Results
2025-11-06 Quarterly Results
2025-08-07 Quarterly Results
2025-05-13 Audited Results

Sai Life Science F&O

Sai Life Science Shareholding Pattern

34.61%
27.8%
3.07%
21.17%
6.12%
7.23%

Sai Life Science FAQs

Sai Life Science share price is ₹1,024 As on 26 April, 2026 | 15:59

The Market Cap of Sai Life Science is ₹21731.3 Cr As on 26 April, 2026 | 15:59

The P/E ratio of Sai Life Science is 65.3 As on 26 April, 2026 | 15:59

The PB ratio of Sai Life Science is 9.2 As on 26 April, 2026 | 15:59

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23